AzTrials
AzTrials

Core Exercises TrainingPTRecoveryNCT04847427

Recovery Kinetics After Different Power Training Protocols (PTRecovery)

A study testing Core exercises training, Structural exercises training and Accentuated eccentric exercises training in people with Core Exercises Training and Structural Exercises Training, run by University of Thessaly at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Muscle power is one of the most important parameters in almost every athletic action, expressing the ability of the human muscle to produce great amounts of force with the greatest possible speed. For enhancing their muscle power, athletes comprise several resistance training programs as part of their training. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
What is being tested?
Core exercises training, Structural exercises training and Accentuated eccentric exercises training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteGreece
Study dates
20 Apr 2021to 30 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • At least 1 year experience in strength exercises
  • Absense of musculoskeletal injuries (≥ 6 months)
  • Abstence from use of ergogenic supplements or other drugs (≥ 1 month)
  • Abstence from participation at exercise with eccentric component (≥ 3 days)
  • Abstence from alcohol and energy drings consumption before each experimental trial

Who cannot join

  • Less than 1 year experience in strength exercises
  • Musculoskeletal injuries (≤ 6 months)
  • Use of ergogenic supplements or other drugs (≤ 1 month)
  • Participation at exercise with eccentric component (≤ 3 days)
  • Alcohol and energy drings consumption before the experimental trials

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • Chariklia K. Deli

    Trikala, Thessaly, 42100

Other trials in Greece

About this study

Official title: Recovery Kinetics of Muscle Performance, Muscle Damage and Neuromuscular Fatigue After Different Protocols of Power Training

Muscle power is one of the most important parameters in almost every athletic action, expressing the ability of the human muscle to produce great amounts of force with the greatest possible speed. For enhancing their muscle power, athletes comprise several resistance training programs as part of their training. However, muscle power training comprises of eccentric muscle actions, which, especially when unaccustomed, can lead to exercise-induced muscle damage and deterioration of muscle performance. Nevertheless, despite the fact that muscle power training comprises eccentric muscle actions, and consequently can lead to muscle injury and muscle performance reduction during the following days, the recovery kinetics after acute muscle power training have not been adequately studied. However, information regarding the recovery of the muscles after a power training protocol, is critical for the correct design of a training microcycle, and the reduction of injury risk. The aim of the present study is to investigate the muscle injury provoked after acute muscle power training using three different power training exercise protocols. Additionally, the effect of these protocols on muscle performance and neuromuscular fatigue indices will be examined.

Read the detailed description

Muscle power is one of the most important parameters in almost every athletic action, and expresses the ability of the human muscle to produce great amounts of force with the greatest possible speed. Thus, muscle power is critical for high performance in athletic actions such as jumping, throwing, change of direction and sprinting. For enhancing their muscle power, athletes comprise several resistance training programs as part of their training. Core exercises as well as Olympic lifting has been used in muscle power training. The loads that are applied regarding the accomplishment of the most favorable power production are varying. Training load of 0% 1RM has been reported to favor power production at the countermovement squat jump, while loads of 56% 1RM and 80% 1RM, favored the power production at squat and clean, respectively. In the recent years, accentuated eccentric training has been proposed as a new training method for the enhancement of muscle power. This method emphasizes in the eccentric component of the muscle contraction, and there is evidence supporting the greater production of muscle force after accentuated eccentric training compared with the typical resistance exercise training method. Taking the above into consideration, muscle power training comprises of eccentric muscle actions, and the magnitude of the eccentric component depends on the emphasis that is given on the concentric or eccentric action, respectively, of the muscles during the exercises. However, eccentric muscle action, especially when unaccustomed, can lead to exercise-induced muscle damage (EIMD). Although concentric and isometric exercise may also lead to muscle injury, the amount of damage after eccentric muscle contractions is greater. EIMD, amongst others, is accompanied by increased levels of creatine kinase (CK) into the circulation, increased delayed onset of muscle soreness (DOMS), reduction of force production, reduction of agility and speed. Despite the fact that muscle power training comprises eccentric muscle actions and consequently can lead to muscle injury and muscle performance reduction during the following days, the recovery kinetics after acute muscle power training protocols have not been adequately studied. However, information regarding the recovery of the muscles after a power training protocol is critical for the correct design of a training microcycle, and the reduction of injury risk.

The aim of the present study is to investigate the muscle injury provoked after acute muscle power training using three different power training exercise protocols. Additionally, the effect of these protocols on muscle performance and neuromuscular fatigue indices will be examined.

According to a preliminary power analysis, a number of 8 - 10 participants is needed for significant differences to be observed at the variables that will be examined (α = 0.90). Thus, 10 participants will be included at the present study.

The study will be performed in a randomized, cross over, repeated measures design. During their 1st - 4th visit, all participants will sign an informed consent (1st visit) after they will be informed about all the benefits and risks of the study and they will fill and sign a medical history form. Participants will be instructed by a dietitian how to record a 7-days diet recall to ensure that they do not consume in greater extent nutrients that may affect EIMD and fatigue (e.g. antioxidants, amino acids, etc.) and to ensure that the energy intake during the trials will be the same. Subsequently, participants will have to be familiarized with the exercises that will be used during the three power training protocols, as well as with the measurements that will be used for the evaluation of performance indices.

During the 5th, 6th, 7th and 8th visit, baseline assessments will be performed. Fasting blood samples will be collected in order to estimate muscle damage concentration markers. Assessment of body mass and body height, body composition, and aerobic capacity (VO2max), will be performed. Squat jump and countermovement jump will be performed on a force platform to assess jump height, ground reaction force, peak and mean power, vertical stiffness and peak rate of force development; at the same time, peak and mean normalized EMG during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles will be assessed. The peak concentric, eccentric and isometric isokinetic torque of the knee flexors and knee extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Maximal voluntary isometric contraction (MVIC) of the knee extensors at 65° in both limbs, as well as the fatigue rate during MVIC through the percent drop of peak torque between the first and the last three seconds of a 10-sec MVIC.

During their 9th visit, participants will be randomly assigned into one of the four different conditions of the study design: a) Core exercises protocol, b) Structural exercises protocol, c) Accentuated eccentric load exercises protocol, d) Control Condition. Prior to each experimental protocol, assessment of DOMS in the knee flexors and knee extensors of both limbs, as well as blood lactate assessment will be performed. Field activity will be continuously recorded during the sprint training protocols using global positioning system (GPS) technology. Heart rate will be continuously recorded during the sprint training protocols using heart rate monitors. Additionally, DOMS of knee flexors and knee extensors, peak concentric, eccentric and isometric isokinetic torque, squat and countermovement jump height, as well as ground reaction force, peak and mean power, vertical stiffness and peak rate of force development during squat and countermovement jump, alongside with peak and mean normalized EMG during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles will be assessed immediately after, 24h, 48h and 72h after the end of the trial. MVIC of the knee extensors of both limbs, as well as the fatigue rate during MVIC will also be assessed at 1h, 2h and 3h, as well as 24h, 48h, and 72h (10th, 11th and 12th visit) after the end of the trial. Blood lactate will also be assessed at 4 min, while creatine kinase at 24h, 48h, and 72h after the end of the trial. The exact same procedure (13rd - 16th visit, 17th - 20th visit, 22nd - 24th visit) will be repeated for the remaining three conditions. A 7-day wash out period will be mediated between trials.

Being tested
Core exercises training, Structural exercises training, Accentuated eccentric exercises training, Control trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Core exercises trainingOther

    Participants will perform:

    1. Squats, 4 sets of 5 repetitions at 60% 1RM
    2. Deadlifts, 4 sets of 5 repetitions at 60% 1RM
    3. Lunges, 4 sets of 5 repetitions at 60% 1RM
    4. Step ups, 4 sets of 5 repetitions at 60% 1RM
  • Structural exercises trainingOther

    Participants will perform:

    1. Snatch, 4 sets of 5 repetitions at 60% 1RM
    2. Hang clean, 4 sets of 5 repetitions at 60% 1RM
    3. Push jerk, 4 sets of 5 repetitions at 60% 1RM
    4. Split push jerk, 4 sets of 5 repetitions at 60% 1RM
  • Accentuated eccentric exercises trainingOther

    Participants will perform:

    1. Deadlifts - squat jump, 4 sets of 5 repetitions at 30% body mass (BM)
    2. Step down - squat jump, 4 sets of 5 repetitions at 30% BM
    3. Step down - lunges, 4 sets of 5 repetitions at 30% BM
    4. Bulgarian squat jumps, 4 sets of 5 repetitions at 30% BM
  • Control trialOther

    Participants will perform all the measurements that are comprised in the experimental conditions without performing any exercise protocol

Study groups in NCT04847427
Study groupRoleWhat they receive
Core exercises trainingExperimentalParticipants will perform 4 core exercises
Receives: Other: Core exercises training
Structural exercises trainingExperimentalParticipants will perform 4 structural (Olympic lifting) exercises
Receives: Other: Structural exercises training
Accentuated eccentric exercises trainingExperimentalParticipants will perform 4 exercises with eccentric loading
Receives: Other: Accentuated eccentric exercises training
Control trialExperimentalParticipants will perform all the measurements that are comprised in the experimental conditions without performing any exercise protocol
Receives: Other: Control trial

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in CK in blood

    Creatine kinase will be measured in plasma using a biochemical analyzer

    Measured: Baseline (pre), 4 minutes post-, 24 hours post-, 48 hours post-, 72 hours post-trial

  2. Change in delayed onset of muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs

    Participants will perform three repetitions of a full squat movement, and rate their soreness level in knee flexors and extensors on a visual analog scale from 1 to 10 (VAS, with "no pain" at one end and "extremely sore" at the other), using palpation of the belly and the distal region of relaxed knee extensors and flexors.

    Measured: Baseline (pre), 4 minutes post-, 24 hours post-, 48 hours post-, 72 hours post-trial

  3. Change in blood lactate

    Blood lactate will be measured in capillary blood with a hand-portable analyzer

    Measured: Baseline (pre), 4 minutes post-trial

  4. Change in squat jump height

    Squat jump height will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate, yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  5. Change in ground reaction force (GRF) during squat jump test

    GRFwill be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate, yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  6. Change in peak power during squat jump test

    Peak power will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate, yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  7. Change in mean power during squat jump test

    Mean power will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate, yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  8. Change in vertical stifness during squat jump test

    Vertical stifness will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate, yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  9. Change in peak normalized EMG during the concentric phase of the squat jump test

    Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles.

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  10. Change in mean normalized EMG during the concentric phase of the squat jump test

    Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles.

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  11. Change in countermovement jump height

    Countermovement jump height will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  12. Change in ground reaction force (GRF) during countermovement jump test

    Ground reaction force will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  13. Change in peak power during countermovement jump test

    Peak power will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), post-, 24h post-, 48h post-, 72h post-trial

  14. Change in mean power during countermovement jump test

    Mean power will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  15. Change in vertical stifness during countermovement jump test

    Vertical stifness will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  16. Change in peak rate of force development during countermovement jump test

    Vertical stifness will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  17. Change in peak normalized EMG during the eccentric and concentric phases of the countermovement jump test

    Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles.

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  18. Change in mean normalized EMG during the eccentric and concentric phases of the countermovement jump test

    Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles.

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  19. Change in concentric peak torque

    Concentric peak torque will be measured on an isokinetic dynamometer

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  20. Change in eccentric peak torque

    Eccentric peak torque will be measured on an isokinetic dynamometer

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  21. Change in isometric peak torque

    Eccentric peak torque will be measured on an isokinetic dynamometer

    Measured: Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial

  22. Change in maximal voluntary isometric contraction (MVIC) during 10 seconds

    MVIC will be measured on an isokinetic dynamometer

    Measured: Baseline (pre), 1 hour post-, 2 hours post-, 3 hours post-, 24 hours post-, 48 hours post-, 72 hours post-trial

  23. Change in fatigue rate during maximal voluntary isometric contraction (MVIC)

    Fatigue rate during MVIC will be estimated through the percent drop of peak torque between the first and the last three seconds of a 10-second maximal isometric contaction

    Measured: Baseline (pre), 1 hour post-, 2 hours post-, 3 hours post-, 24 hours post-, 48 hours post-, 72 hours post-trial

  24. Differences in field activity between the three different power training protocols

    Field activity will be continuously recorded during the power training protocols using global positioning system (GPS) technology

    Measured: During each power training protocol

  25. Change in heart rate between the three different power training protocols

    Heart rate will be continuously recorded during during the power training protocols using heart rate monitors

    Measured: During each power training protocol

Secondary outcomes (7)
  1. Body weight

    Body weight will be measured on a beam balance/stadiometer

    Measured: Baseline

  2. Body height

    Body height will be measured on a beam balance/stadiometer

    Measured: Baseline

  3. Body mass index (BMI)

    BMI will be calculated from the ratio of body mass/ body height squared

    Measured: Baseline

  4. Maximal oxygen consumption (VO2max)

    Maximal oxygen consumption will be measured by open circuit spirometry via breath by breath method

    Measured: Baseline

  5. Body fat

    Body fat will be measured by using Dual-emission X-ray absorptiometry

    Measured: Baseline

  6. Lean body mass

    Lean body mass will be measured by using Dual-emission X-ray absorptiometry

    Measured: Baseline

  7. Dietary intake

    Dietary intake will be assessed using 7-day diet recalls

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2021
  2. Study start20 Apr 2021
  3. Primary completion30 Nov 2021
  4. Study completion30 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04847427
Sponsor's protocol ID
Power training - Recovery
Acronym
PTRecovery
Status last verified
Feb 2022
First submitted
10 Feb 2021
Last updated
18 Feb 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Clarkson PM, Byrnes WC, McCormick KM, Turcotte LP, White JS. Muscle soreness and serum creatine kinase activity following isometric, eccentric, and concentric exercise. Int J Sports Med. 1986 Jun;7(3):152-5. doi: 10.1055/s-2008-1025753.

    PubMed 3733311
  • Deli CK, Fatouros IG, Paschalis V, Georgakouli K, Zalavras A, Avloniti A, Koutedakis Y, Jamurtas AZ. A Comparison of Exercise-Induced Muscle Damage Following Maximal Eccentric Contractions in Men and Boys. Pediatr Exerc Sci. 2017 Aug;29(3):316-325. doi: 10.1123/pes.2016-0185. Epub 2017 Feb 6.

    PubMed 28165870
  • Kyrolainen H, Avela J, McBride JM, Koskinen S, Andersen JL, Sipila S, Takala TE, Komi PV. Effects of power training on muscle structure and neuromuscular performance. Scand J Med Sci Sports. 2005 Feb;15(1):58-64. doi: 10.1111/j.1600-0838.2004.00390.x.

    PubMed 15679573
  • Ispirlidis I, Fatouros IG, Jamurtas AZ, Nikolaidis MG, Michailidis I, Douroudos I, Margonis K, Chatzinikolaou A, Kalistratos E, Katrabasas I, Alexiou V, Taxildaris K. Time-course of changes in inflammatory and performance responses following a soccer game. Clin J Sport Med. 2008 Sep;18(5):423-31. doi: 10.1097/JSM.0b013e3181818e0b.

    PubMed 18806550
  • Hughes JD, Massiah RG, Clarke RD. The Potentiating Effect of an Accentuated Eccentric Load on Countermovement Jump Performance. J Strength Cond Res. 2016 Dec;30(12):3450-3455. doi: 10.1519/JSC.0000000000001455.

    PubMed 27100315
  • Cormie P, McCaulley GO, Triplett NT, McBride JM. Optimal loading for maximal power output during lower-body resistance exercises. Med Sci Sports Exerc. 2007 Feb;39(2):340-9. doi: 10.1249/01.mss.0000246993.71599.bf.

    PubMed 17277599
  • Walker S, Blazevich AJ, Haff GG, Tufano JJ, Newton RU, Hakkinen K. Greater Strength Gains after Training with Accentuated Eccentric than Traditional Isoinertial Loads in Already Strength-Trained Men. Front Physiol. 2016 Apr 27;7:149. doi: 10.3389/fphys.2016.00149. eCollection 2016.

    PubMed 27199764

Questions about this trial

What is this clinical trial studying?

A study testing Core exercises training, Structural exercises training and Accentuated eccentric exercises training in people with Core Exercises Training and Structural Exercises Training, run by University of Thessaly at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in CK in blood (time frame: Baseline (pre), 4 minutes post-, 24 hours post-, 48 hours post-, 72 hours post-trial). The study lists 25 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04847427, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in